“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: HER2 overexpression in gastroesophageal adenocarcinoma, prognostic and predictive value and diagnostic approach

€2.42

SKU: product-article-8475 Category: General

Description

Description

HER2 overexpression in gastroesophageal adenocarcinoma, prognostic and predictive value and diagnostic approach

Top

Article: HER2 overexpression in gastroesophageal adenocarcinoma, prognostic and predictive value and diagnostic approach

Description

Related products

Article: Highlights in respiratory oncology

Article: INTRODUCTION

Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma

Article: Calendar of events